278
Views
23
CrossRef citations to date
0
Altmetric
Original Article

On the Role and Significance of Fas (Apo-1/CD95) Ligand (FasL) Expression in Immune Privileged Tissues and Cancer Cells Using Multiple Myeloma as a Model*

, &
Pages 477-490 | Received 04 Feb 1998, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mine Hekimgil, Seçkin Çağirgan, Mustafa Pehlivan, Başak Doğanavşargil, Murat Tombuloğlu & Saliha Soydan. (2006) Immunohistochemical detection of CD 95 (Fas) & Fas ligand (Fas-L) in plasma cells of multiple myeloma and its correlation with survival. Leukemia & Lymphoma 47:2, pages 271-280.
Read now
Quan Chen, Subrata Ray, Mohamad A. Hussein, Gordan Srkalovic & Alexandru Almasan. (2003) Role of Apo2L/TRAIL and Bcl-2-family Proteins in Apoptosis of Multiple Myeloma. Leukemia & Lymphoma 44:7, pages 1209-1214.
Read now

Articles from other publishers (21)

Simone Stensgaard, Astrid Thomsen, Sofie Helstrup, Peter Meldgaard & Boe S. Sorensen. (2023) Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor. Cancers 15:23, pages 5628.
Crossref
Giuseppe Murdaca, Alessandro Allegra, Francesca Paladin, Fabrizio Calapai, Caterina Musolino & Sebastiano Gangemi. (2021) Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma. International Journal of Molecular Sciences 22:16, pages 9039.
Crossref
Gergely Milosevits, János Szebeni & Silke Krol. (2015) Exosomes: potential model for complement-stealth delivery systems. European Journal of Nanomedicine 7:3.
Crossref
Nilay Nandi, Abhik Sen, Rajdeep Banerjee, Sudeep Kumar, Vikash Kumar, Amar Nath Ghosh & Pradeep Das. (2010) Hydrogen peroxide induces apoptosis-like death in Entamoeba histolytica trophozoites. Microbiology 156:7, pages 1926-1941.
Crossref
Franziska B. Mullauer, Jan H. Kessler & Jan Paul Medema. (2010) Betulinic acid, a natural compound with potent anticancer effects. Anti-Cancer Drugs 21:3, pages 215-227.
Crossref
Helge Bertram, Andreas Nerlich, Georg Omlor, Florian Geiger, Gerald Zimmermann & Joerg Fellenberg. (2009) Expression of TRAIL and the death receptors DR4 and DR5 correlates with progression of degeneration in human intervertebral disks. Modern Pathology 22:7, pages 895-905.
Crossref
Tanya Das, Gaurisankar Sa, Ewa Paszkiewicz-Kozik, Cynthia Hilston, Luis Molto, Patricia Rayman, Daisuke Kudo, Kaushik Biswas, Ronald M. Bukowski, James H. Finke & Charles S. Tannenbaum. (2008) Renal Cell Carcinoma Tumors Induce T Cell Apoptosis through Receptor-Dependent and Receptor-Independent Pathways. The Journal of Immunology 180:7, pages 4687-4696.
Crossref
Michal Lotem, Arthur Machlenkin, Shoshana Frankenburg & Tamar Peretz. 2008. Innate and Adaptive Immunity in the Tumor Microenvironment. Innate and Adaptive Immunity in the Tumor Microenvironment 157 170 .
Ramy Ibrahim, Helen Frederickson, Allyson Parr, Yvona Ward, Joel Moncur & Samir N. Khleif. (2006) Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanism. Cancer 106:5, pages 1065-1077.
Crossref
Richard Greil, Gabriele Anether, Karin Johrer & Inge Tinhofer. (2003) Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools. Journal of Leukocyte Biology 74:3, pages 311-330.
Crossref
H Zangger, J C Mottram & N Fasel. (2002) Cell death in Leishmania induced by stress and differentiation: programmed cell death or necrosis?. Cell Death & Differentiation 9:10, pages 1126-1139.
Crossref
ASTRID HAMMER, MICHAELE HARTMANN, PETER SEDLMAYR, WOLFGANG WALCHER, GABY KOHNEN & GOTTFRIED DOHR. (2002) Expression of Functional Fas Ligand in Choriocarcinoma. American Journal of Reproductive Immunology 48:4, pages 226-234.
Crossref
Stephen Maher, Deirdre Toomey, Claire Condron & David Bouchier‐Hayes. (2002) Activation‐induced cell death: The controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunology & Cell Biology 80:2, pages 131-137.
Crossref
Steven R. Danielson, Alice Wong, Valerio Carelli, Andrea Martinuzzi, Anthony H.V. Schapira & Gino A. Cortopassi. (2002) Cells Bearing Mutations Causing Leber's Hereditary Optic Neuropathy Are Sensitized to Fas-induced Apoptosis. Journal of Biological Chemistry 277:8, pages 5810-5815.
Crossref
Rongcun Yang, Dawei Xu, Anju Zhang & Astrid Gruber. (2001) Immature dendritic cells kill ovarian carcinoma cells by a FAS/FASL pathway, enabling them to sensitize tumor-specific CTLs. International Journal of Cancer 94:3, pages 407-413.
Crossref
J. D. Mountz, G. E. Van Zant, H.-G. Zhang, W. E. Grizzle, R. Ahmed, R. W. Williams & H.-C. Hsu. (2001) Genetic Dissection of Age-Related Changes of Immune Function in Mice. Scandinavian Journal of Immunology 54:1-2, pages 10-20.
Crossref
Steven P. Treon, Constantine Mitsiades, Nicholas Mitsiades, Gloria Young, Deborah Doss, Robert Schlossman & Kenneth C. Anderson. (2001) Tumor Cell Expression of CD59 Is Associated With Resistance to CD20 Serotherapy in Patients With B-Cell Malignancies. Journal of Immunotherapy 24:3, pages 263-271.
Crossref
Jong-Beom Park, Han Chang & Ki-Won Kim. (2001) Expression of Fas Ligand and Apoptosis of Disc Cells in Herniated Lumbar Disc Tissue. Spine 26:6, pages 618-621.
Crossref
Jong-Beom Park, Ki-Won Kim, Chang-Whan Han & Han Chang. (2001) Expression of Fas Receptor on Disc Cells in Herniated Lumbar Disc Tissue. Spine 26:2, pages 142-146.
Crossref
Hans G. Drexler & Yoshinobu Matsuo. (2000) Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leukemia Research 24:8, pages 681-703.
Crossref
Robert W. GeorgantasIIIIII, Kam W. Leong & J. Thomas August. (2000) Antigen-Specific Induction of Peripheral T Cell Tolerance in Vivo by Codelivery of DNA Vectors Encoding Antigen and Fas Ligand . Human Gene Therapy 11:6, pages 851-858.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.